Dogwood Therapeutics Inc.

NASDAQ: DWTX · Real-Time Price · USD
4.82
-0.08 (-1.63%)
At close: Sep 18, 2025, 3:59 PM
4.85
0.62%
After-hours: Sep 18, 2025, 05:48 PM EDT

Dogwood Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-12.35M -5.3M -12.25M -15.96M
Depreciation & Amortization
12.18K n/a n/a n/a
Stock-Based Compensation
476.02K 619.97K 582.66K 322.88K
Other Working Capital
-801.16K 266.81K -21.92K -322.2K
Other Non-Cash Items
3.65M n/a n/a n/a
Deferred Income Tax
-503 n/a n/a n/a
Change in Working Capital
-581.27K -194.45K 197.38K -52.19K
Operating Cash Flow
-8.79M -4.87M -11.47M -15.69M
Capital Expenditures
5.00 n/a -3 n/a
Cash Acquisitions
3.76M n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
3.76M n/a n/a n/a
Debt Repayment
15.32M n/a n/a n/a
Common Stock Repurchased
-351 n/a n/a -295.17K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 197.56K
Financial Cash Flow
16.7M 1.16M 4.49M -97.6K
Net Cash Flow
11.53M -3.71M -6.98M -15.79M
Free Cash Flow
-8.79M -4.87M -11.47M -15.69M